Article Figures & Data
Tables
Study Population Age Data Reference Standard Country Risk of Bias Referral setting (ENT, respiratory, or allergy clinic) McNeill,13 1963 Adults and children (n = 150, 242 sinuses) referred to ENT clinic for clinically suspected ARS Range ≥10 y (10-19 y, n = 22; ≥20 y, n = 128) Radiography showing mucosal thickening or any opacity Northern Ireland High Axelsson et al,21 1976 Consecutive adults (n = 164) at ENT clinic with clinically suspected acute maxillary sinusitis Mean 35 y Radiography (at least 4 views) showing any mucosal thickening, air-fluid levels, or opacification Sweden Moderate Berg et al,15 1981 Adults (n = 50) at ENT clinic with clinically suspected ARS of ≥3 weeks duration Mean 46 y Antral puncture revealing purulent discharge Sweden High Berg et al,22 1985 Adults (n = 90) at ENT clinic with clinically suspected ARS of ≥3 weeks duration Not reported Antral puncture revealing purulent discharge Sweden Moderate van Buchem et al,5 1995 Adults (n = 113) referred to ENT clinic with clinically suspected acute maxillary sinusitis 42% 18-29 y; 34% 30-44 y; 16% 45-59 y; and 9% ≥60 y (1) Antral puncture showing fluid or floccules (by patient) and (2) bacterial culture of fluid (by sinus) Netherlands Low Visca et al,23 1995 Children (n = 30) at pediatric respiratory clinic with clinically suspected ARS Range 5-15 y CT scan abnormal in coronal projection Italy High Huang et al,24 2008 Consecutive adults and children (n = 217) at allergy clinic with clinically suspected ARS of <3 weeks duration Range 4-61 y (4-9 y, n = 89; 10-19 y, n = 101; ≥20 y, n = 27) Sinus radiograph (n = 151) or CT scan (n = 12) with >4 mm mucosal thickening, air-fluid levels, and/or increased opacity or retention cyst USA High Primary care, urgent care, or emergency department setting Berg et al,25 1988 Adults (n = 155) presenting to ED with clinically suspected maxillary sinusitis of <3 months duration Mean 38 y Antral puncture with return of purulent or cloudy fluid Sweden Moderate Williams et al,26 1992 Consecutive men (n = 247) presenting to VA general medicine clinic with <3 months of self-described sinusitis or at least 1 sinus symptom–median symptom duration of 11 days Median 50 y, IQ range 40-63 y Radiographs (4 views): mucosal thickening ≥6 mm, complete opacity, or air-fluid level USA Moderate van Duijn et al,27 1992 Adults (n = 400, 441 episodes) presenting to primary care clinic with clinically suspected ARS Range ≥15 y Ultrasonography abnormal Netherlands Moderate Hansen et al,4 1995 Consecutive adults (n = 174) at primary care clinic suspected of having acute maxillary sinusitis by their general practitioner Median 35 y, range 18-65 y CT scan abnormal and culture of purulent fluid positive for pathogenic bacteria Denmark Low Lindbaek et al,12 1996 Adults (n = 201) clinically diagnosed by primary care doctor with ARS requiring antibiotics Mean 37.8, range 15-83 y CT scan showing air-fluid level or complete opacification Norway High Laine et al,28 1998 Consecutive adults (n = 39) presenting to primary care clinic with clinically suspected acute maxillary sinusitis of <30 days duration Median 37 y, range 16-68 y Nasal aspirate with purulent or mucopurulent material Finland Low Varonen et al,29 2003 Consecutive adults (n = 148) presenting to a primary care clinic with clinically suspected ARS of <30 days duration, 72% >5 days Mean 39.7 y, range 18-75 y Sinus radiographs (AP and Waters’ views) showing total opacification, air-fluid level, or mucosal thickening ≥6 mm Finland High Thomas et al,30 2006 Adults (n = 60) presenting to a VA urgent care center with clinically suspected ARS of <4 weeks duration Mean 51 y, range 25-83 y CT scan showing air-fluid level or complete opacification (mucosal thickening alone was not considered diagnostic) USA Moderate Shaikh et al,31 2013 Children (n = 258) at a general pediatric clinic with clinically suspected ARS of <30 days durations (mean symptom duration 14 days) Mean 6.4 y, range 2.0-12.9 y Radiographs (AP and Water’s views): complete opacification or any mucosal thickening USA Moderate Autio et al,32 2015 Adults (n = 50) presenting to a military clinic with clinically suspected ARS of <4 days duration (symptoms recorded at 9-10 days after onset) Mean 20 y, range 18-23 y CT followed by antral puncture and bacterial culture if positive Finland Low AP = anteroposterior; ARS = acute rhinosinusitis; CT = computed tomography; ED = emergency department; ENT = ear, nose, and throat; IQ = interquartile; USA = United States of America; VA = Veterans Administration.
Study Reference Standard No. Prevalence, % Studies of adults Berg et al,15 1981 Antral puncturea 50 50 Berg et al,22 1985 Antral puncturea 90 48 Berg et al,25 1988 Antral puncturea 155 44 Hansen et al,4 1995 Antral puncturea 174 53 Van Buchem et al,5 1995 Antral puncturea 108 49 Laine et al,28 1998 Antral puncturea 39 51 Summary for antral puncture, % (95% CI) 49 (45-53) Hansen et al,4 1995 Bacterial cultureb 174 35 Van Buchem et al,5 1995 Bacterial cultureb 113 34 Autio et al,32 2015 Bacterial cultureb 43 19 Summary for bacterial culture, % (95% CI) 31 (24-40) Lindbaek et al,12 1996 CT 201 63 Thomas et al,30 2006 CT 60 45 Van Duijn et al,27 1992 Ultrasound 423 49 Varonen et al,29 2003 Radiograph 32 41 Williams et al,26 1992 Radiograph 247 39 Axelsson et al,21 1976 Radiograph 164 63 Summary for imaging, % (95% CI) 51 (48-54) Summary for studies with adults only, % (95% CI) 48 (42-54) Studies of adults and children McNeill,13 1963 Radiograph 242 56 Huang et al,24 2008 Radiograph 217 70 Summary for studies with adults and children, % (95% CI) 63 (49-75) Studies of children Visca et al,23 1995 CT 30 57 Shaikh et al,31 2013 Radiograph 258 79 Summary for studies with children only, % (95% CI) 70 (45-87) Sign or Symptom # of Studies Sensitivity (95% CI) Specificity (95% CI) LR+ (95% CI)a LR− (95% CI)a DOR (95% CI)b Overall clinical impression 4 0.73 (0.66-0.79) 0.75 (0.64-0.84) 3.0 (2.1-4.4)c 0.37 (0.29-0.46)c 8.3 (4.9-13.1)c Symptoms Nasal speech 3 0.51 (0.15-0.85) 0.73 (0.35-0.93) 1.9 (1.3-2.7)c 0.67 (0.37-0.91)c 2.9 (1.8-4.3)c Pain in teeth 8 0.34 (0.21-0.50) 0.80 (0.63-0.90) 1.8 (1.2-2.5)c 0.83 (0.74-0.90)c 2.1 (1.4-3.0)c Nasal discharge Purulent 10 0.71 (0.63-0.78) 0.54 (0.48-0.61) 1.6 (1.4-1.7)c 0.54 (0.44-0.56)c 2.9 (2.2-3.7)c Any 4 0.75 (0.57-0.91) 0.49 (0.35-0.68) 1.5 (1.3-1.8)c 0.49 (0.24-0.82)c 3.5 (1.7-6.2)c Maxillary or frontal pain 3 0.49 (0.15-0.83) 0.63 (0.14-0.95) 1.50 (0.86-3.50) 0.89 (0.61-1.40) 1.90 (0.61-4.50) Maxillary pain Unilateral 5 0.30 (0.14-0.52) 0.80 (0.51-0.94) 1.50 (0.96-2.60) 0.90 (0.79-1.00)c 1.70 (0.92-3.00) Location not specified 5 0.70 (0.42-0.88) 0.20 (0.05-0.51) 0.88 (0.73-1.00)c 1.60 (0.95-2.80) 0.60 (0.30-1.10) Cacosmiad 5 0.23 (0.15-0.33) 0.84 (0.58-0.95) 1.50 (0.63-3.70) 0.96 (0.83-1.20) 1.70 (0.53-4.30) Double sickening 3 0.74 (0.32-0.95) 0.41 (0.13-0.77) 1.30 (0.77-2.40) 0.69 (0.20-1.50) 2.70 (0.49-8.50) Hyposmia or anosmia 8 0.61 (0.52-0.70) 0.54 (0.46-0.61) 1.3 (1.1-1.5)c 0.72 (0.59-0.87)c 1.9 (1.3-2.5)c Cough Nocturnal 3 0.89 (0.80-0.94) 0.11 (0.06-0.19) 0.99 (0.87-1.10) 1.20 (0.43-2.60) 1.10 (0.35-2.60) Any 7 0.69 (0.57-0.80) 0.40 (0.27-0.55) 1.3 (1.0-1.7)c 0.78 (0.60-0.98)c 1.5 (1.0-2.2)c Preceding respiratory tract infection 5 0.87 (0.66-0.96) 0.27 (0.13-0.48) 1.2 (1.1 -1.3)c 0.48 (0.30-0.72)c 2.6 (1.6-4.0)c Pain bending forward 5 0.72 (0.56-0.84) 0.39 (0.24-0.57) 1.2 (1.0-1.5)c 0.71 (0.50-0.97)c 1.70 (0.97-2.70) Nasal congestion or obstruction 9 0.83 (0.74-0.89) 0.24 (0.14-0.36) 1.1 (1.0-1.2)c 0.73 (0.56-0.93)c 1.5 (1.1-2.1)c Fatigue or malaise 6 0.62 (0.51-0.71) 0.45 (0.32-0.59) 1.10 (0.99-1.30) 0.86 (0.72-1.00)c 1.30 (0.98-1.80) Sneezing 3 0.63 (0.49-0.74) 0.39 (0.31-0.48) 1.00 (0.86-1.20) 0.96 (0.71-1.20) 1.10 (0.70-1.20) Headache 6 0.50 (0.32-0.67) 0.50 (0.27-0.73) 1.00 (0.71-1.30) 1.00 (0.79-1.40) 1.00 (0.57-1.70) Allergies by history 3 0.19 (0.16-0.24) 0.79 (0.72-0.85) 0.96 (0.64-1.40) 1.00 (0.93-1.10) 0.96 (0.57-1.50) Postnasal drip 3 0.74 (0.55-0.87) 0.19 (0.07-0.45) 0.94 (0.73-1.30) 1.50 (0.64-3.40) 0.80 (0.23-2.00) Previous sinusitis 4 0.59 (0.52-0.65) 0.27 (0.18-0.39) 0.81 (0.71-0.93)c 1.6 (1.1-2.2)c 0.55 (0.33-0.83)c Signs Purulent secretions Middle meatus 5 0.15 (0.07-0.28) 0.95 (0.87-0.98) 3.2 (1.4-6.6)c 0.90 (0.78-0.97)c 3.7 (1.5-7.6)c Pharyngeal or postnasal 7 0.14 (0.06-0.30) 0.92 (0.77-0.97) 1.8 (1.1-2.8)c 0.93 (0.87-0.98)c 2.0 (1.2-3.1)c Any nasal 12 0.39 (0.28-0.51) 0.74 (0.63-0.82) 1.50 (0.99-2.30) 0.84 (0.67-1.00)c 1.90 (0.98-3.30) Transillumination abnormal 3 0.69 (0.63-0.75) 0.56 (0.50-0.62) 1.6 (1.4-1.9)c 0.55 (0.44-0.67)c 3.0 (2.0-4.2)c Sinus tenderness Frontal 3 0.25 (0.09-0.54) 0.75 (0.47-0.91) 1.10 (0.76-1.40) 0.99 (0.86-1.10) 1.10 (0.70-1.60) Maxillary 12 0.44 (0.28-0.61) 0.49 (0.34-0.64) 0.88 (0.57-1.30) 1.20 (0.80-1.60) 0.81 (0.37-1.30) Nasal mucosal thickening 3 0.82 (0.27-0.98) 0.30 (0.15-0.51) 1.10 (0.49-1.40) 0.68 (0.09-1.60) 3.00 (0.32-13.00) Temperature >38° C 7 0.11 (0.07-0.19) 0.87 (0.79-0.92) 0.94 (0.42-1.90) 1.00 (0.91-1.10) 0.94 (0.37-2.10) ARS = acute rhinosinusitis; DOR = diagnostic odds ratio; LR+ = positive likelihood ratio; LR− = negative likelihood ratio.
Note: Each sign or symptom was reported in 3 or more studies to be included here.
↵a A likelihood ratio near 1.0 means that the test adds little diagnostic information, a likelihood ratio >1 increases the likelihood of disease, and a likelihood ratio <1 decreases the likelihood of disease.
↵b The diagnostic odds ratio is LR+ divided by LR− and is an overall measure of diagnostic discrimination.
↵c Value is significantly < or > 1.0.
↵d Cacosmia is fetid odor on patient’s breath.
- Table 4
Accuracy of Signs and Symptoms of ABRS Diagnosed by Purulent Antral Puncture or Positive Bacterial Culture
Sign or Symptom # of Studies Sensitivity (95% CI) Sensitivity (95% CI) LR+ (95% CI)a LR− (95% CI)a DOR (95% CI)b Overall clinical impression 3 0.74 (0.61-0.84) 0.80 (0.72-0.87) 3.9 (2.4-5.9)c 0.33 (0.20-0.50)c 13.0 (5.0-27)c Symptoms Cacosmiad 3 0.23 (0.11-0.42) 0.93 (0.59-0.99) 4.3 (0.94-14) 0.86 (0.76-0.99)c 5.0 (0.74-18) Pain in teeth 3 0.38 (0.10-0.78) 0.80 (0.37-0.97) 2.0 (1.1-3.7)c 0.77 (0.50-0.96)c 2.7 (1.3-4.6)c Purulent nasal discharge 3 0.64 (0.45-0.79) 0.50 (0.36-0.63) 1.3 (0.99-1.6) 0.74 (0.47-1.0) 1.8 (0.98-3.2) Pain bending forward 3 0.64 (0.4-0.79) 0.38 (0.20-0.60) 1.0 (0.87-1.3) 0.95 (0.69-1.3) 1.2 (0.69-1.8) Nasal congestion or obstruction 4 0.71 (0.57-0.82) 0.25 (0.10-0.52) 0.98 (0.83-1.3) 1.3 (0.70-2.3) 0.88 (0.38-1.8) Cough 3 0.66 (0.34-0.86) 0.29 (0.12-0.55) 0.93 (0.70-1.1) 1.2 (0.79-1.7) 0.84 (0.45-1.4) Physical examination Sinus tenderness, maxillary 5 0.33 (0.13-0.61) 0.57 (0.40-0.73) 0.86 (0.23-2.2) 1.2 (0.55-2.1) 0.97 (0.11-3.9) Nasal discharge, purulent 5 0.27 (0.20-0.35) 0.66 (0.45-0.82) 0.88 (0.36-1.9) 1.2 (0.57-1.8) 0.83 (0.22-2.3) ABRS = acute rhinosinusitis; DOR = diagnostic odds ratio; LR+ = positive likelihood ratio; LR− = negative likelihood ratio.
Note: Each sign or symptom was reported in 3 or more studies to be included here.
↵a A likelihood ratio near 1.0 means that the test adds little diagnostic information, a likelihood ratio >1 increases the likelihood of disease, and a likelihood ratio <1 decreases the likelihood of disease.
↵b The diagnostic odds ratio is LR+ divided by LR− and is an overall measure of diagnostic discrimination.
↵c Value is significantly < or > 1.0.
↵d Cacosmia is fetid odor on patient’s breath.
- Table 5
Combinations of Findings and Clinical Decision Rules for the Diagnosis of Acute Sinusitis
Study Reference Standard Findings Interpretation Result Likelihood Ratio (95% CI) Probability of Sinusitis, %a Diagnosis of ARS Huang et al,24 2008b Radiograph (n = 205) or CT (n = 12) Leukocyte esterase: <1+ = 0, 1+ = 2, ≥2+ = 3 4-11 127.0 (8.1-2016.0) 99 2-3 0.23 (0.10-0.52) 13 pH: <7.5 = 0, 7.5 = 1, 8.0 = 2, 8.5 = 3
Nitrite: none = 0, light pink = 1, dark pink = 2
Protein: <2+ = 0, 2+ = 1, 3+ = 2, 4+ = 30-1 0.00 (0.00-0.06) 0 Lindbaek et al,12 1996 CT Double sickening 4 25.0 (3.5-177.0) 94 Purulent secretion in nasal cavity 3 1.8 (1.1-3.2) 55 Purulent rhinorrhea (symptom) 2 0.81 (0.51-1.30) 35 ESR >10 0-1 0.16 (0.09-0.30) 10 Williams et al,26 1992 Radiograph Maxillary toothache 4-5 6.4 (2.2-19.0) 81 Abnormal transillumination 3 2.6 (1.5-4.4) 63 Poor response to decongestants or antihistamines 2 1.10 (0.73-1.70) 42 1 0.43 (0.27-0.80) 22 Colored nasal discharge
Mucopurulence on examination0 0.16 (0.04-0.41 10 Van Diujn et al,27 1992 Ultrasound (A mode) Beginning with common cold 5 … 89c Purulent rhinorrhea 1-4 … 18-82 Pain at bending
Unilateral maxillary pain
Pain in teeth0 … 11 Diagnosis of ABRS Berg et al,25 1988 Purulent antral puncture fluid Purulent rhinorrhea with unilateral predominance 3-4 7.0 (3.9-12.7) 82 2 1.30 (0.72-1.9) 46 Local pain with unilateral predominance
Bilateral purulent rhinorrhea
Pus in nasal cavity0-1 0.06 (0.02-0.17) 4 Ebell et al,36 2017 Positive bacterial culture from antral fluid Tender maxillary sinus (unilateral): 2 points 7-8 5.0 (1.8-14) 77 4-6 1.8 (1.3-2.5) 55 Maxillary toothache: 2 points
C-reactive protein >15 mg/L: 2 points
Preceding upper respiratory tract illness: 1 point
Purulent nasal discharge: 1 point
Previous sinusitis episodes: −1 point−1-3 0.35 (0.21-0.56) 19 ABRS = acute bacterial rhinosinusitis; ARS = acute rhinosinusitis; CT = computed tomography; ESR = erythrocyte sedimentation rate; LR = likelihood ratio.
↵a Calculated using the score-specific LR and a pretest probability of 40%, or taken directly from logistic model for each study.
↵b Results obtained from application of a urinalysis dipstick to nasal secretions.
↵c Probability of sinusitis calculated directly from logistic regression, so LR and its CI not estimable. Each variable is assigned a value of 1 for the presence of each finding and 0 for the absence. The score = −2.124 + 1.035*(beginning with common cold) + 0.996*(purulent rhinorrhea) + 0.95*(pain at bending) + 0.64*(unilateral maxillary pain) + 0.606*(pain in the teeth). A person with all findings present would have a maximum score of 2.103. The probability of sinusitis is calculated from exp(score)/[1 + exp(score)], so exp(2.103)/[1 + exp(2.103)]=89%. A person with none of the findings present would have a score of −2.124, or a probability of 11%.
Additional Files
Supplemental Tables & Figure
Supplemental tables and figure
Files in this Data Supplement:
- Supplemental data: Tables & Figure - PDF file
The Article in Brief
Accuracy of Signs and Symptoms for the Diagnosis of Acute Rhinosinusitis and Acute Bacterial Rhinosinusitis
Mark H. Ebell , and colleagues
Background Although acute rhinosinusitis (sinus inflammation) is the most common reason for outpatient prescription of antibiotics, only about one-third of patients with sinus symptoms have a confirmed bacterial pathogen that is amenable to antibiotics. Helping physicians more accurately identify patients with acute bacterial rhinosinusitis could reduce inappropriate antibiotic use and its harms. This study analyzes existing research to evaluate the accuracy of signs and symptoms of acute rhinosinusitis.
What This Study Found Based on an analysis of existing research, three symptoms can help clinicians identify patients with the bacterial rhinosinusitis. These symptoms include clinical impression (the clinician's preliminary or working diagnosis), pain in the teeth, and bad breath. Acute rhinosinusitis, which may be viral or bacterial, is significantly less likely in patients without nasal discharge, without a complaint of purulent nasal discharge (yellow to green mucus), and in those with normal transillumination (light can be transmitted through the sinuses and is not blocked by secretions). Clinical decision rules for the diagnosis of both acute and acute bacterial rhinosinusitis have not yet been prospectively validated.